a Molex company, will have a major exhibiting and speaking presence at
the 8th Annual InnoPack Pharma Confex, to be held May 21 – 22
in Mumbai. As an established global leader, Phillips-Medisize provides a
wide range of custom drug delivery devices, connected health solutions
and end-to-end manufacturing services to Asian, European and U.S.
pharmaceutical companies and is actively expanding its footprint in
On Day 1 (May 21) at 12:30 p.m., Bill Welch, Chief Technology Officer,
Phillips-Medisize, will speak to pharma companies on how to reach the
market faster and expedite product development with proven technology
accelerators for all types of infusion, injection and inhalation
devices. His presentation – “Transforming Drug Delivery” – will explain
how to gain a competitive edge with human-centered design for
customizable and user-friendly devices along with technology solutions
that support global commercialization.
On Day 2 (May 22) at 10:30 a.m., Welch will moderate a panel discussion
of cutting-edge packaging experts on the “Importance of Connected
Devices in Improving Patient Experiences.” This session will address the
role of connected patient-use drug delivery devices in healthcare
Throughout InnoPack, Welch and other Phillips-Medisize executives will
be at the company’s booth –A6 – to discuss the latest breakthroughs in
drug delivery and to demonstrate how its innovative connected health
solutions and powerful analytics are helping to improve patient
engagement and adherence. From device design, development and
manufacturing to the company’s award-winning, FDA registered Connected
Health Platform (CHP), Phillips-Medisize is transforming drug delivery
around the world.
“Our primary business focus is on complex, regulated drug delivery
devices and connected health solutions,” Welch said. “Together with our
customers, we challenge and push the limits of product design and
development to help transform the diagnosis and delivery of healthcare.”
Phillips-Medisize will also participate in a Packaging Leaders
Roundtable – new at this year’s InnoPack – where top industry experts
will deliberate critical areas of pharma packaging and drug delivery.
The company’s thought-leaders will discuss opportunities to advance
pharma packaging in India today and in the future.
By creating its Global Innovation and Development (GID) center in
Bangalore, Phillips-Medisize is committed to building a healthcare
focused team within the well-established Molex capabilities already in
place there. This will help us better support customers in the region as
they work on developing more intelligent drug delivery solutions.
“The added focus on healthcare in our India-based office, hiring of a
senior business development director and continued investment in staff
demonstrates our dedication to providing the right expertise, solutions
and services that make a difference to our valued customers and their
patients. We are thrilled to participate for the second year at InnoPack
and anticipate continued success in this promising market,” added Matt
Jennings, CEO and President of Phillips-Medisize.
Phillips-Medisize, LLC, a Molex company, is an end-to-end provider of
innovation, development and manufacturing solutions to the
pharmaceutical, diagnostics, and medical device market segments. Backed
by the combined global resources of Molex and its parent company Koch
Industries, Phillips-Medisize’s core advantage is the knowledge of its
people to integrate design, molding, electronics, and automation,
providing innovative, high-quality manufacturing solutions. For more
information, please visit www.phillipsmedisize.com